Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Go back to Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
(NASDAQ: BBNX) Delayed: 22.04 --0 (-0%)
Previous Close $22.04    52 Week High
Open $22.04    52 Week Low
Day High $22.04    P/E N/A 
Day Low $22.04    EPS
Volume 5,617